Literature DB >> 370810

Early outbreaks of 'epidemic neuromyasthenia'.

J G Parish.   

Abstract

The literature of the outbreaks of 'epidemic neuromyasthenia' (ENM) from 1934 to 1955 has been selected to show that the disease affects other people besides young adult females in hospitals and nursing homes. There have been district epidemics, in which the male: female ratio was almost even and several male outbreaks affecting soldiers in barracks. Some outbreaks appear to have been triggered off by an epidemic of poliomyelitis, and the epidemiology of outbreaks in Iceland in 1948 and 1955 suggests that the normal cytopathological effects of poliomyelitis infection have been suppressed by the new disease. In the Durban epidemic (1955) a toxic metabolite was discovered in the urine of many patients and a markedly increased urinary excretion of creatine was noted in two New York State outbreaks. The results of the transmission of an agent from patients with ENM to monkeys suggest that the neurological disorder might be in the form of mild disseminated lesions scattered throughout the nervous system from the brain to peripheral nerves and associated with perivascular round cell infiltration without significant cellular damage. ENM infection was widespread in the North of England in 1955 and associated with lymphocyte abnormalities, which have persisted in some cases for several years. This suggests a continuous organic process.

Entities:  

Mesh:

Year:  1978        PMID: 370810      PMCID: PMC2425322          DOI: 10.1136/pgmj.54.637.711

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN: 0032-5473            Impact factor:   2.401


  18 in total

1.  EPIDEMIC NEUROMYASTHENIA. OUTBREAK IN A CONVENT IN NEW YORK STATE.

Authors:  R M ALBRECHT; V L OLIVER; D C POSKANZER
Journal:  JAMA       Date:  1964-03-21       Impact factor: 56.272

2.  Epidemic myalgic encephalomyelopathy: the Durban outbreak.

Authors:  R C HILL; R W CHEETHAM; H L WALLACE
Journal:  Lancet       Date:  1959-04-04       Impact factor: 79.321

3.  Epidemic neuromyasthenia; clinical syndrome.

Authors:  D A HENDERSON; A SHELOKOV
Journal:  N Engl J Med       Date:  1959-04-09       Impact factor: 91.245

4.  Further investigations on a disease resembling poliomyelitis seen in Adelaide.

Authors:  R A PELLEW; J A MILES
Journal:  Med J Aust       Date:  1955-09-24       Impact factor: 7.738

5.  A disease resembling poliomyelitis; report of an outbreak in Johannesburg.

Authors:  A L JACKSON; S JACOBSON; B COOPER
Journal:  S Afr Med J       Date:  1957-05-25

6.  Epidemic neuromyasthenia; an outbreak of poliomyelitislike illness in student nurses.

Authors:  A SHELOKOV; K HABEL; E VERDER; W WELSH
Journal:  N Engl J Med       Date:  1957-08-22       Impact factor: 91.245

7.  [Encephalitis myalgica epidemica, a poliomyelitis-like disease; epidemic neuromyasthenia, benign myalgic encephalomyelitis].

Authors:  O GSELL
Journal:  Schweiz Med Wochenschr       Date:  1958-05-17

8.  Response to poliomyelitis vaccination.

Authors:  B SIGURDSSON; M GUDNADOTTIR; G PETURSSON
Journal:  Lancet       Date:  1958-02-15       Impact factor: 79.321

9.  Clinical findings six years after outbreak of Akureyri disease.

Authors:  B SIGURDSSON
Journal:  Lancet       Date:  1956-05-26       Impact factor: 79.321

10.  [Not Available].

Authors:  O GSELL
Journal:  Helv Med Acta       Date:  1949-09
View more
  14 in total

1.  Postviral fatigue syndrome.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1988-04-09

2.  Postviral fatigue syndrome.

Authors:  A J Pelosi; A S David; S Wessely
Journal:  Br Med J (Clin Res Ed)       Date:  1988-05-07

Review 3.  Accurate diagnosis of myalgic encephalomyelitis and chronic fatigue syndrome based upon objective test methods for characteristic symptoms.

Authors:  Frank Nm Twisk
Journal:  World J Methodol       Date:  2015-06-26

Review 4.  The post-viral syndrome: a review.

Authors:  M I Archer
Journal:  J R Coll Gen Pract       Date:  1987-05

Review 5.  What SARS-CoV-2 does to our brains.

Authors:  Tom Aschman; Ronja Mothes; Frank L Heppner; Helena Radbruch
Journal:  Immunity       Date:  2022-06-20       Impact factor: 43.474

6.  Sensory and cognitive event-related potentials in myalgic encephalomyelitis.

Authors:  D Prasher; A Smith; L Findley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-03       Impact factor: 10.154

7.  Neurohumoral and haemodynamic profile in postural tachycardia and chronic fatigue syndromes.

Authors:  Luis E Okamoto; Satish R Raj; Amanda Peltier; Alfredo Gamboa; Cyndya Shibao; André Diedrich; Bonnie K Black; David Robertson; Italo Biaggioni
Journal:  Clin Sci (Lond)       Date:  2012-02       Impact factor: 6.124

8.  Replacing Myalgic Encephalomyelitis and Chronic Fatigue Syndrome with Systemic Exercise Intolerance Disease Is Not the Way forward.

Authors:  Frank N M Twisk
Journal:  Diagnostics (Basel)       Date:  2016-02-05

Review 9.  The Enterovirus Theory of Disease Etiology in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Critical Review.

Authors:  Adam J O'Neal; Maureen R Hanson
Journal:  Front Med (Lausanne)       Date:  2021-06-18

Review 10.  A Molecular Neurobiological Approach to Understanding the Aetiology of Chronic Fatigue Syndrome (Myalgic Encephalomyelitis or Systemic Exertion Intolerance Disease) with Treatment Implications.

Authors:  Jean A Monro; Basant K Puri
Journal:  Mol Neurobiol       Date:  2018-02-06       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.